Genzyme Executive VP-Legal And Corporate Development Peter Wirth: An Interview With “The Pink Sheet” DAILY (Part 1 of 3)

Wirth talks about growing Genzyme through acquisitions and diversifying its revenue base from an early focus solely on rare enzyme deficiency diseases.